AXGN
Price
$17.05
Change
-$0.64 (-3.62%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
348.67M
27 days until earnings call
TCMD
Price
$13.64
Change
-$0.22 (-1.59%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
369.35M
39 days until earnings call
Ad is loading...

AXGN vs TCMD

Header iconAXGN vs TCMD Comparison
Open Charts AXGN vs TCMDBanner chart's image
Axogen
Price$17.05
Change-$0.64 (-3.62%)
Volume$16.16K
Capitalization348.67M
Tactile Systems Technology
Price$13.64
Change-$0.22 (-1.59%)
Volume$2.27K
Capitalization369.35M
AXGN vs TCMD Comparison Chart
Loading...
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXGN vs. TCMD commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXGN is a Hold and TCMD is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (AXGN: $17.69 vs. TCMD: $13.86)
Brand notoriety: AXGN and TCMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AXGN: 74% vs. TCMD: 49%
Market capitalization -- AXGN: $348.67M vs. TCMD: $369.35M
AXGN [@Medical Specialties] is valued at $348.67M. TCMD’s [@Medical Specialties] market capitalization is $369.35M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXGN’s FA Score shows that 0 FA rating(s) are green whileTCMD’s FA Score has 1 green FA rating(s).

  • AXGN’s FA Score: 0 green, 5 red.
  • TCMD’s FA Score: 1 green, 4 red.
According to our system of comparison, AXGN is a better buy in the long-term than TCMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXGN’s TA Score shows that 2 TA indicator(s) are bullish while TCMD’s TA Score has 6 bullish TA indicator(s).

  • AXGN’s TA Score: 2 bullish, 7 bearish.
  • TCMD’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, TCMD is a better buy in the short-term than AXGN.

Price Growth

AXGN (@Medical Specialties) experienced а -5.90% price change this week, while TCMD (@Medical Specialties) price change was +3.59% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.32%. For the same industry, the average monthly price growth was +1.69%, and the average quarterly price growth was +1.51%.

Reported Earning Dates

AXGN is expected to report earnings on Apr 30, 2025.

TCMD is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Medical Specialties (-4.32% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCMD($369M) has a higher market cap than AXGN($349M). AXGN YTD gains are higher at: 7.342 vs. TCMD (-19.089). TCMD has higher annual earnings (EBITDA): 24.5M vs. AXGN (-13.33M). TCMD has more cash in the bank: 75.2M vs. AXGN (31M). TCMD has less debt than AXGN: TCMD (50.4M) vs AXGN (69.3M). TCMD has higher revenues than AXGN: TCMD (274M) vs AXGN (159M).
AXGNTCMDAXGN / TCMD
Capitalization349M369M95%
EBITDA-13.33M24.5M-54%
Gain YTD7.342-19.089-38%
P/E RatioN/A12.72-
Revenue159M274M58%
Total Cash31M75.2M41%
Total Debt69.3M50.4M138%
FUNDAMENTALS RATINGS
AXGN vs TCMD: Fundamental Ratings
AXGN
TCMD
OUTLOOK RATING
1..100
810
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
65
Fair valued
PROFIT vs RISK RATING
1..100
70100
SMR RATING
1..100
9376
PRICE GROWTH RATING
1..100
3975
P/E GROWTH RATING
1..100
10013
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AXGN's Valuation (47) in the Medical Specialties industry is in the same range as TCMD (65). This means that AXGN’s stock grew similarly to TCMD’s over the last 12 months.

AXGN's Profit vs Risk Rating (70) in the Medical Specialties industry is in the same range as TCMD (100). This means that AXGN’s stock grew similarly to TCMD’s over the last 12 months.

TCMD's SMR Rating (76) in the Medical Specialties industry is in the same range as AXGN (93). This means that TCMD’s stock grew similarly to AXGN’s over the last 12 months.

AXGN's Price Growth Rating (39) in the Medical Specialties industry is somewhat better than the same rating for TCMD (75). This means that AXGN’s stock grew somewhat faster than TCMD’s over the last 12 months.

TCMD's P/E Growth Rating (13) in the Medical Specialties industry is significantly better than the same rating for AXGN (100). This means that TCMD’s stock grew significantly faster than AXGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXGNTCMD
RSI
ODDS (%)
Bearish Trend 7 days ago
75%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 7 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
AXGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRGIX14.69N/A
N/A
Nuveen Core Equity Retire
CVQZX8.59N/A
N/A
Columbia Disciplined Value Inst
PMDDX17.56N/A
N/A
Principal Small-MidCap Dividend Inc C
JFACX33.80N/A
N/A
JHancock Fundamental All Cap Core R2
MISEX33.77N/A
N/A
Midas Magic

TCMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCMD has been loosely correlated with AXGN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TCMD jumps, then AXGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCMD
1D Price
Change %
TCMD100%
+1.91%
AXGN - TCMD
43%
Loosely correlated
-0.67%
OFIX - TCMD
42%
Loosely correlated
+1.81%
AORT - TCMD
40%
Loosely correlated
+1.54%
CERS - TCMD
36%
Loosely correlated
+1.45%
UTMD - TCMD
36%
Loosely correlated
-0.39%
More